Nutriband (NTRB) Competitors

Nutriband (NASDAQ:NTRB) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Do analysts rate NTRB or LUNG?

Nutriband currently has a consensus price target of $13.00, indicating a potential upside of 144.36%. Pulmonx has a consensus price target of $12.75, indicating a potential upside of 146.62%. Given Pulmonx's higher possible upside, analysts plainly believe Pulmonx is more favorable than Nutriband.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutriband	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pulmonx	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Is NTRB or LUNG more profitable?

Pulmonx has a net margin of -67.31% compared to Nutriband's net margin of -338.51%. Nutriband's return on equity of -54.49% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nutriband	-338.51%	-54.49%	-48.52%
Pulmonx	-67.31%	-55.36%	-33.53%

Do insiders and institutionals have more ownership in NTRB or LUNG?

19.7% of Nutriband shares are held by institutional investors. Comparatively, 91.0% of Pulmonx shares are held by institutional investors. 54.1% of Nutriband shares are held by company insiders. Comparatively, 6.8% of Pulmonx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has preferable earnings and valuation, NTRB or LUNG?

Nutriband has higher earnings, but lower revenue than Pulmonx. Nutriband is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutriband	$2.02M	29.22	-$5.49M	-$0.71	-7.49
Pulmonx	$83.79M	2.48	-$60.84M	-$1.44	-3.59

Does the media refer more to NTRB or LUNG?

In the previous week, Pulmonx had 2 more articles in the media than Nutriband. MarketBeat recorded 5 mentions for Pulmonx and 3 mentions for Nutriband. Pulmonx's average media sentiment score of 1.05 beat Nutriband's score of 0.25 indicating that Pulmonx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nutriband	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pulmonx	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, NTRB or LUNG?

Nutriband has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500.

Does the MarketBeat Community believe in NTRB or LUNG?

Pulmonx received 32 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 45.57% of users gave Pulmonx an outperform vote while only 44.44% of users gave Nutriband an outperform vote.

Company	Underperform	Outperform
Nutriband	Outperform Votes 4 44.44%	Underperform Votes 5 55.56%
Pulmonx	Outperform Votes 36 45.57%	Underperform Votes 43 54.43%

Summary

Pulmonx beats Nutriband on 11 of the 18 factors compared between the two stocks.